TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, will be exhibiting at the Innovators & Investors Forum on Tuesday 3 February at the Business Design Centre, London.
TyraTech's management will be showcasing the Company's products at stand 20 throughout the day. TyraTech's Chief Executive Officer, Bruno Jactel, will conduct a presentation at 3.00pm in the Babbage Room.
Innovators & Investors Forum, sponsored by Cenkos and Shares magazine, is a one-day conference and exhibition which aims to showcase pioneering and imaginative technology-led firms and bring them together with the investment community. The event will run from 9.00am to 6.00pm with the conference agenda starting at 2.00pm. For more information including registration details visit http://www.msmconferences.com/event/iif2014/?view=Home
For further information please contact:
TyraTech Inc. Bruno Jactel, Chief Executive Officer Vincent Morgus, Chief Financial Officer Alan Reade, Non-Executive Chairman |
Tel: +1 919 415 4340 Tel: +1-919-415-4287 Tel: +44 78 4197 8709 |
SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 |
Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: 44 20 3328 5656 |
Whitman Howard, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: 44 20 7087 4550 |
Walbrook, Financial PR and IR Bob Huxford /Guy McDougall |
Tel: +44 20 7933 8792 |
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.